LigaChem Biosciences Inc. (KOSDAQ:141080)
South Korea · Delayed Price · Currency is KRW 147,400
+8,600 (6.20%)
Jul 18, 2025, 3:30 PM KST
LigaChem Biosciences Company Description
LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs.
It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs.
The company was formerly known as LegoChem Biosciences, Inc. and changed its name to LigaChem Biosciences Inc. in April 2024.
LigaChem Biosciences Inc. was founded in 2006 and is headquartered in Daejeon, South Korea.
LigaChem Biosciences Inc.
| Country | South Korea |
| Founded | 2006 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 170 |
| CEO | Yong Kim |
Contact Details
Address: 10, Gukjegwahak 10-ro Daejeon, 34002 South Korea | |
| Phone | 82 4 2861 0688 |
| Website | ligachembio.com |
Stock Details
| Ticker Symbol | 141080 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| ISIN Number | KR7141080002 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Yong Kim | Chief Executive Officer |
| Sejin Park | Chief Financial Officer |
| Sejin Park | Chief Operating Officer |